santa cruz biotechnology, inc.
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
BSP Antikörper
BSPII (bone sialoprotein II), also known as IBSP (integrin-binding sialoprotein), BSP (bone sialoprotein), BNSP or SP-II, is a secreted acidic glycosylated, sulfated and phosphorylated protein that is synthesized by osteoblasts, osteocytes, osteoclasts, hypertrophic chondroctyes and other skeletal-associated cell types. BSPII is a major structural protein in bone matrix and makes up approximately 12% of the noncollagenous proteins in human bone. Noncollagenous proteins are believed to function in the regulation of bone mineralization. BSPII is capable of nucleating hydroxyapatite crystal formation and, therefore, is thought to play an important role in initial mineralization of bone, cementum and dentin. Belonging to the SIBLING family of proteins, BSPII contains an RGD sequence which recognizes the vitronectin receptor Integrin åV and may participate in mediating cell attachment. In addition, BSPII is expressed in various cancers, including lung, thyroid, breast and prostate cancers.
BSP Antikörper
BSP specific siRNA, shRNA Plasmid and shRNA Lentiviral Particles gene silencers include:
| |||||||||||||||||||||||||||||||||||||||||||||||
